C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2002
11/28/2002	US20020177722 Method for the preparation of citalopram
11/28/2002	US20020177717 Compounds and methods for the inhibition of the expression of VCAM-1
11/28/2002	US20020177708 (R)-chiral halogenated substituted N-benzyl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/28/2002	US20020177622 Neuroprotectants; enhancing cognition
11/28/2002	US20020177598 Inhibit activity of chemokines, macrophage inflammatory protein-1 (MIP-1 alpha) and RANTES; 1-((4-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine for example
11/28/2002	US20020177594 Inhibitors of histone deacetylase
11/28/2002	US20020177589 Novel amines as histamine-3 receptor ligands and their therapeutic applications
11/28/2002	DE10125432A1 New benzoyl-substituted aliphatic ketones or aldehydes, useful as herbicides or fungicides, especially as pre- and post-emergence selective herbicides against a broad spectrum of weeds
11/28/2002	DE10125145A1 New C-furanyl- or C-thienyl-methylamine derivatives, useful e.g. for treating arrhythmia, emesis, inflammation, cardiovascular or neurodegenerative disease, asthma, glaucoma or especially pain
11/28/2002	CA2445010A1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors
11/27/2002	EP1260498A1 Novel color former and recording material
11/27/2002	EP1260223A1 Taxanes having furyl or thienyl substituted side-chain
11/27/2002	EP1259501A2 Method for the preparation of citalopram
11/27/2002	EP1259500A1 Method for the preparation of citalopram
11/27/2002	EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002	EP1259478A1 Covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids functionally active on the cb2 cannabinoid receptor
11/27/2002	EP1259121A2 Weight loss induced by reduction in neuropeptide y level
11/27/2002	EP0825982B1 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/27/2002	EP0777492A4 Combinatorial libraries of substrate-bound cyclic organic compounds
11/27/2002	EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002	CN1382150A Hydromycin derivatives
11/27/2002	CN1382149A Hygromycin A prodrugs
11/27/2002	CN1382133A Method for preparing benzofuran or benzothiophene compound
11/27/2002	CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/27/2002	CN1381450A Process for preparing glycoaldehyde from cane dregs
11/27/2002	CN1094934C Production process of maleic anhydride
11/27/2002	CN1094791C Improved catalysts for hydrogenation of maleic acid to 1,4-butanediol
11/27/2002	CN1094789C Catalyst for preparing gamma-butyrolactone by dehydrogenation of 1,4-butanediol and its application
11/26/2002	US6486366 Method for producing alcohols by hydrogenation of carbonyl compounds
11/26/2002	US6486357 Catalytic oxidation of alcohols using manganese oxides
11/26/2002	US6486343 Substituted phenyl keto enols as pesticides and herbicides
11/26/2002	US6486342 Substituted chiral allosteric hemoglobin modifiers
11/26/2002	US6486325 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
11/26/2002	US6486324 Forming libraries of bactericides; immobilization; side effect reduction
11/26/2002	US6486202 Inhibitors of isoprenyl transferase
11/26/2002	US6486201 Agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
11/26/2002	US6486200 Prodrugs for antimicrobial amidines
11/26/2002	US6486196 Anticancer compounds: process for their preparation and pharmaceutical compositions containing them
11/26/2002	US6486194 Alzheimer's disease
11/26/2002	US6486178 Indane derivatives
11/26/2002	US6486164 Used for treatment of neuropsychological disorders including schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, parkinson-like motor disorders and motion disorders neuroleptic agents.
11/26/2002	CA2055174C Process for the synthesis of alpha-((dialkylamino) substituted-methylene)-beta-oxo-(substituted) propanenitriles
11/26/2002	CA2051855C Process for producing n-substituted-1-deoxynojirimycin
11/21/2002	WO2002092590A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
11/21/2002	WO2002092582A1 Protease-inhibitors
11/21/2002	WO2002092574A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	WO2002092564A2 Synthesis of cyclopentadiene derivatives
11/21/2002	WO2002092547A1 Method for producing ketones from carboxylic acid anhydrides
11/21/2002	WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002	WO2002078832A3 Supercritical fluids or dense phase gases formed from liquid precursors
11/21/2002	WO2002064539A3 Method for the production of phthalic anhydride to a specification
11/21/2002	WO2002057246A3 Inhibitors of cruzipain and other cysteine proteases
11/21/2002	US20020173668 Diels-alder adducts of epoxybutene and epoxybutene derivatives
11/21/2002	US20020173666 Process for preparing a deuterated or tritiated compound
11/21/2002	US20020173543 Compounds for altering mitochondrial function and cellular responses
11/21/2002	US20020173512 Psychological disorders; antidepressants
11/21/2002	US20020173500 Hypotensive agents; antiischemic agents
11/21/2002	US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002	US20020173469 Protease inhibitors
11/21/2002	US20020173422 Oxidative reactions using membranes that selectively conduct oxygen
11/21/2002	DE10138576A1 New substituted benzoylcyclohexenone derivatives useful as antimicrobials and herbicides, especially for selective application in transgenic crops
11/21/2002	DE10124041A1 New peptide-type compounds, useful as protease, especially thrombin, inhibitors for treating e.g. thrombosis and cardiac infarct
11/21/2002	DE10123909A1 Production of ketone compounds useful in pharmacological applications, comprising reacting boronic acid derivatives with carboxylic acid anhydrides in presence of transition metal catalysts, based on palladium, nickel, platinum or copper
11/21/2002	DE10112828C1 Preparation of high purity citalopram comprises a cyanide exchange reaction followed by thin film distillation and recrystallization from methanol and water
11/21/2002	CA2447416A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	CA2447232A1 Method for producing ketones from carboxylic acid anhydrides
11/21/2002	CA2446797A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
11/21/2002	CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/20/2002	EP1258491A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2002	EP1258473A1 Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
11/20/2002	EP1258471A2 Inorganic ion receptor-active compounds
11/20/2002	EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002	EP1257519A1 Chemical transformation of substrates using nonmetallic, organic catalyst compositions
11/20/2002	EP1257265A2 Use of 2-phenylene diamine derivatives for the treatment of infections
11/20/2002	EP1257264A1 Estrogen receptor modulators
11/20/2002	EP1147101B1 Reverse hydroxamate inhibitors of matrix metalloproteinases
11/20/2002	EP1077966B1 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/20/2002	CN1381076A Nonaqueous electrolytic solution and secondary battery containing the same
11/20/2002	CN1380883A Novel derivatives and analogues of galanthamin
11/19/2002	US6482962 Contacting helminth, nematode, insect or acarid pests or parasites or their food supply, habitat or breeding grounds with a nitroethyl derivative
11/19/2002	US6482959 Process for the stereoselective reduction of α,β-unsaturated ketones
11/19/2002	US6482943 Quinones as disease therapies
11/19/2002	US6482851 Synthesis of dysidiolide and uses thereof
11/19/2002	US6482849 Inhibitors of α4β1 mediated cell adhesion
11/19/2002	US6482651 Aromatic esters for marking or tagging petroleum products
11/19/2002	US6482478 Fluorinated derivatives of phenanthrene and the utilization thereof in liquid crystal mixtures
11/14/2002	WO2002090341A1 Process for the production of 5-benzyl-3-furfuryl alcohol
11/14/2002	WO2002090331A1 Method for producing 1,3-disubstituted 2-nitroguanidines
11/14/2002	WO2002064550A8 Glucocorticoid receptor modulators
11/14/2002	WO2002048133A3 A process for the preparation of citalopram
11/14/2002	US20020169326 Fatty acid derivatives
11/14/2002	US20020169316 Process for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl) dioxazines
11/14/2002	US20020169215 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology
11/14/2002	US20020169188 Modulating neurotransmission in the central nervous system
11/14/2002	US20020169184 Low molecular weight, non-peptide
11/14/2002	US20020169164 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1256568A1 Intermediates for the preparation of enantiomerically pure cyclopentane and cyclopentene beta amino acids
11/13/2002	EP1256564A1 Halogen-containing aromatic compound
11/13/2002	EP1255746A1 Oxy- and amino-substituted tetrahydrofuryl derivatives with antimour activity

1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 472